Pulled Pain Pill, Opioid Rates Show Need For Research
Endo International PLC's recent decision to yank its painkiller Opana ER from the market, following pressure from the U.S. Food and Drug Administration to stop sales of the abuse-linked drug and...To view the full article, register now.
Already a subscriber? Click here to view full article